Mukherjee Debabrata
Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY 40536-0200, USA.
Congest Heart Fail. 2008 Mar-Apr;14(2):75-82. doi: 10.1111/j.1751-7133.2008.07453.x.
Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase (COX-2) inhibitors, or "coxibs," are used for a number of disease conditions for relief of pain and inflammation. Currently available data suggest concern for prothrombotic risk with coxibs and some NSAIDs, and the magnitude of risk may vary with individual agents. NSAIDs and coxibs also increase blood pressure, worsen hypertension control, and may precipitate heart failure, with important differences among agents. Physicians should consider patterns of risk and benefit in selecting the most appropriate agent for individual patients based on the individual gastrointestinal and cardiovascular risk profile.
非甾体抗炎药(NSAIDs)和选择性环氧化酶(COX-2)抑制剂,即“昔布类药物”,用于多种疾病状况以缓解疼痛和炎症。现有数据表明,人们对昔布类药物和某些非甾体抗炎药的血栓形成风险存在担忧,且风险程度可能因药物种类而异。非甾体抗炎药和昔布类药物还会升高血压、使高血压控制恶化,并可能引发心力衰竭,不同药物之间存在重要差异。医生应根据个体的胃肠道和心血管风险状况,在为个体患者选择最合适的药物时考虑风险和获益模式。